| Related Articles |
Management of acute massive pulmonary embolism: Is surgical embolectomy inferior to thrombolysis?
Int J Cardiol. 2015 Oct 31;203:579-583
Authors: Cho YH, Sung K, Kim WS, Jeong DS, Lee YT, Park PW, Kim DK
Abstract
BACKGROUND: Although current guidelines for pulmonary embolism (PE) treatment recommend surgical embolectomy when thrombolysis is contraindicated or has failed, their clinical outcomes rarely have been compared directly.
METHODS: After excluding patients aged under 18years and those with submassive or non-massive PE, 45 consecutive patients (median age, 68years; 62% female; 31% experienced cardiac arrest before PE treatment onset; 33% had cancer diagnosis history; and 29% received extracorporeal membrane oxygenation [ECMO]) who underwent only thrombolysis (TL group; n=19) or surgical embolectomy (SE group; n=26, including 4 who had failed thrombolysis) for acute massive PE from 2000 to 2013 at Samsung Medical Center were enrolled to assess cardiac mortality as primary outcome.
RESULTS: Median follow-up duration was 17.2months. In the SE group, significantly higher proportions of patients had recent surgery and ECMO. Overall 30-day all-cause mortality rate was 24% (n=11), without significant difference between the SE (15%) and TL (37%) groups (P=0.098); however, cardiac mortality rate was significantly higher in the TL than SE group (Log rank P=0.023). TL was an independent multivariate predictor of cardiac death (P=0.03).
CONCLUSION: In this small retrospective single center experience, surgical embolectomy is associated with lower cardiac mortality risk than thrombolysis, which might render it first-line treatment option for acute massive PE for patients without life-limiting comorbidities.
PMID: 26569368 [PubMed - as supplied by publisher]